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ABSTRACT 
 Methionine adenosyltransferase from Euglena gracilis (MATX) is a recently 
discovered member of the MAT family of proteins that synthesize S-adenosylmethionine. 
Heterologous overexpression of MATX in Escherichia coli rendered the protein mostly in 
inclusion bodies under all conditions tested. Therefore, a refolding and purification 
procedure from these aggregates was developed to characterize the enzyme. Maximal 
recovery was obtained using inclusion bodies devoid of extraneous proteins by washing 
under mild urea (2 M) and detergent (5%) concentrations. Refolding was achieved in two 
steps following solubilization in the presence of Mg2+; chaotrope dilution to <1 M and 
dialysis under reducing conditions. Purified MATX is a homodimer that exhibits Michaelis 
kinetics with a Vmax of 1.46 µmol/min/mg and Km values of approximately 85 and 260 µM 
for methionine and ATP, respectively. The activity is dependent on Mg2+ and K+ ions, but 
is not stimulated by dimethylsulfoxide. MATX exhibits tripolyphosphatase activity that is 
stimulated in the presence of S-adenosylmethionine. Far-UV circular dichroism revealed 
β-sheet and random coil as the main secondary structure elements of the protein. The high 
level of sequence conservation allowed construction of a structural model that preserved 
the main features of the MAT family, the major changes involving the N-terminal domain. 
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INTRODUCTION 
 Reactions using S-adenosylmethionine (AdoMet) are among the most abundant 
processes taking place in any cell [1,2]. The routes in which the AdoMet-consuming 
reactions are involved allow the synthesis of a large variety of compounds, as well as the 
control of cell function (i.e. epigenetic modifications). This wide use of AdoMet derives 
from the variety of groups that this molecule is able to donate, being methyl group 
donation the main consumer of the compound [2-5]. In contrast, methionine 
adenosyltransferases (MATs) are the only enzymes known to synthesize AdoMet in a 
rather unusual reaction that occurs in two steps [6,7]. First, the substrates methionine and 
ATP are combined to obtain AdoMet and triphosphate that is hydrolyzed in the second part 
of the reaction to render pyrophosphate and inorganic phosphate as side products. The 
catalytic mechanism followed is of the SN2 type and most of the inorganic phosphate 
obtained derives from the γ-phosphate of ATP [6,7]. MATs require divalent cations (Mg2+) 
for catalysis and are activated by monovalent ions (K+). In mammals, AdoMet has a dual 
behavior on MATs, inhibiting (MAT I and II) and activating (MAT III) its own synthesis, 
and enhancing the tripolyphosphatase activity [2,8,9].  
 MAT enzymes have been found in almost every organism from Mycoplasma 
genitalium to mammals with the exception of a few parasites that obtain AdoMet from 
their hosts [10]. For this purpose, AdoMet transporters are required and proteins exhibiting 
such function have been identified in some organisms, as well as in yeast and mammalian 
mitochondria [11-13]. Most organisms express several MAT isoenzymes that differ in their 
affinities for the substrates (30 µM to 1 mM for methionine in mammals), despite the high 
conservation of the sequences of their catalytic subunits [2,7,14]. Most members of the 
MAT family are homo-oligomers except for mammalian MAT II, and the majority are 
tetramers with the exception of a few dimers (i.e. mammalian MAT III and archaeal 
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MATs) [7,15]. All the crystal structures known to date (mammalian and E. coli MATs) 
show monomers organized in three domains formed by nonconsecutive stretches of the 
sequence, and the subunits interact through a large flat hydrophobic surface to form the 
dimers [7,16-18]. Active sites, two per dimer, locate between monomers with residues of 
both subunits contributing to them, thus the minimum association level of active MATs is 
the dimer. Sequence and structural restrictions to maintain the relative positions of the 
active site residues, and the unusual reaction mechanism, impose that the insertions and 
deletions observed in specific lineages take place mostly in the loops [10]. Moreover, these 
indels are conserved in the lineages in which they occur as observed in the analysis carried 
out in Bacteria and Eukarya. Recently, a different type of eukaryotic MAT (MATX) was 
identified in dinoflagellates, haptophytes, diatoms and euglenids [19,20]. This new MAT 
preserves the catalytic residues, its sequence contains insertions/deletions in loops and it is 
able to complement the corresponding Saccharomyces cerevisiae mutant, thus 
demonstrating its capacity to synthesize AdoMet [21]. Several species express both a 
canonical MAT and this new MATX, hence raising the possibility that the characteristics 
of each isoenzyme favor adaptation to the growth conditions or the diverse needs during 
the life cycle of the organism. The purpose of this article is to fully characterize MATX 
and compare its properties with those of other members of the MAT family. Differences in 
the active sites among MATs may provide the basis for the use/design of inhibitors for 
selective growth control of certain organisms, and hence the infections they produce that 
may have important pathological or commercial consequences. 
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MATERIALS AND METHODS 
 
Materials 
 Methinonine, ATP, S-adenosylmethionine (AdoMet) dithiothreitol (DTT), 
ampicillin, molecular mass standards for gel filtration chromatography and protease 
inhibitors were obtained from Sigma Chemical Company (St. Louis, MO). [2,8-3H]-ATP 
(28.7 Ci/mmol), Pfu DNA polymerase and restriction enzymes were products of Perkin 
Elmer (Boston, MA), Biotools (Madrid, Spain) and Invitrogen (Carlsbad, CA), 
respectively. Q-Sepharose HiTrap and Superose 12 10/300 GL columns were purchased 
from GE Healthcare (Uppsala, Sweden). Isopropyl β-D-thiogalactopyranoside (IPTG) and 
E. coli strains were products of Calbiochem (La Jolla, CA) and Stratagene (La Jolla, CA), 
respectively. Electrophoresis reagents and the BioRad protein assay kit were obtained from 
BioRad (Richmond, CA). YM-30 ultrafiltration membranes were purchased from Amicon 
Corp. (Beverly, MA). Urea, DMSO and Triton X-100 were products from Merck 
(Darmstadt, Germany). The rest of the buffers and reagent were from the best quality 
commercially available. 
 
Construction of MATX expression plasmids 
 The ORF of MATX was amplified by PCR from the pEXT5-MATX plasmid 
provided by Dr. A. Rogers’s laboratory. For this purpose, primers that include NdeI (5’-
GGAATTCCATATGGCTGAATCTGCTTCAAAG-3’) and EcoRI (5’-GCGAATTCCTA 
GTCCACCCACTTCTG-3’) restriction sites (underlined) were designed. Following an 
initial denaturation step at 95ºC for 2 min, amplification was performed for 30 cycles at 
95ºC for 30 s, 55ºC for 1 min and 72 ºC for 1 min using Pfu DNA polymerase. The PCR 
also included a final elongation step at 72ºC for 10 min. The PCR fragment was then 
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purified, digested and cloned into the pT7.7 vector [22] using the NdeI and EcoRI 
restriction sites. The resulting plasmid was designated pT7.7-MATX. The sequence was 
verified by automatic sequencing at the facilities of the Instituto de Investigaciones 
Biomédicas “Alberto Sols”. 
 
MATX overexpression in E. coli 
 The pT7.7-MATX plasmid was transformed into BL21(DE3) Codon Plus 
competent cells and single colonies were grown in LB medium (500 ml) containing 50 
µg/ml ampicillin at 20ºC, 30ºC and 37ºC. The cell density was measured and aliquots (25 
ml) taken and induced at A600=0-0.8 using 0.5 mM IPTG for 0-22 h. Cells were harvested 
by centrifugation and stored at -80ºC until processing. 
 
Analysis of soluble and insoluble fractions 
 Cell pellets (1 g wet wt) were lysed by sonication at 4ºC in a Soniprep 150 sonifier 
(15 cycles, 30 s on/off at an output power level of 8 microns) in 25 ml of 50 mM Tris/HCl 
pH 8, 10 mM MgSO4 (buffer A) containing 5 mM EDTA, 0.1 % 2-mercaptoethanol, 2 
µg/ml aprotinin, 1 µg/ml pepstatin A, 0.5 µg/ml leupeptin, 2.5 µg/ml antipain, 0.5 mM 
benzamidine, 0.1 mM phenylmethylsulfonyl fluoride (PMSF). Soluble and insoluble 
fractions were separated by centrifugation at 13000g for 15 min. The insoluble fraction, 
containing the inclusion bodies, was solubilized in 10 ml of 50 mM Tris/HCl pH 8, 75 mM 
MgSO4 containing 8 M urea and aliquots prepared for SDS-PAGE. In parallel, soluble 
fractions were used for both SDS-PAGE and activity measurements.   
 
MATX refolding from inclusion bodies 
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 The insoluble fraction obtained from 1 g of cells was resuspended in 25 ml of 
buffer A containing 1 mM EDTA and sonicated again 6 cycles (10 s on/off, output power 8 
microns) on ice. Pellets were recovered by centrifugation for 30 min at 48000g and 4ºC. 
These pellets were used to test washing conditions using 100 mM Tris/HCl pH 7 buffers 
including 5 mM EDTA, 0-4 M urea, 0-5 % Triton X-100 and 0.1 mM benzamidine. These 
washes were carried out twice, followed by a final wash with the same buffer devoid of 
urea and detergent.  
 One washed pellet was resuspended in 10 ml of 50 mM Tris/HCl pH 8 containing 8 
M urea and 75 mM MgSO4 and incubated for 2 hours at 10ºC. Thereafter the sample was 
diluted to reach 0.5-4 M urea by addition of buffer A. Each diluted sample was 
immediately dialyzed against buffer A containing 10 mM DTT (total volume 1.5 l). 
Refolded MATX was recovered by centrifugation of the dialyzed samples for 30 min at 
48000g and 4ºC, and checked for MAT activity and protein. 
 
Purification of refolded MATX  
 Refolded MATX was purified using Q-Sepharose HiTrap (5 ml) equilibrated in 
buffer A containing 0.1 % 2-mercaptoethanol and 0.1 mM benzamidine. The flow rate was 
1 ml/min and 5 ml fractions were collected. Following sample loading an extensive 
washing step (100 ml) was carried out using buffer A until A280=0. Elution was performed 
with a gradient from 0-0.5 M KCl in buffer A (150 ml) at the same flow rate. The presence 
of MATX was detected by activity measurements and the corresponding peak collected 
and dialyzed against buffer A to eliminate KCl excess or against 50 mM Tris/HCl pH 8 for 
Mg2+ kinetics. In some cases, the peak was concentrated by ultrafiltration using YM-30 
membranes until the desired protein concentration was reached. 
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Far and near UV circular dichroism 
MATX samples were prepared at 0.25 mg/ml and 1 mg/ml protein concentrations 
for far- and near-UV CD, respectively. Spectra were recorded on a Jasco J-720 
spectropolarimeter at 25ºC, using 0.1 cm (far-UV) or 1 cm (near-UV) pathlength cuvettes. 
After baseline subtraction the observed ellipticities were converted to mean residue 
ellipticities (θmrw) on the basis of a mean molecular mass per residue of 110 Da. A 
minimum of five spectra was taken for each sample. Analysis of secondary structure was 
performed using the deconvolution software CDNN (© G. Böhm). 
 
Sedimentation velocity 
MATX samples (0.3-0.5 mg/ml) were used for sedimentation velocity runs that 
were carried out at 48000 rpm and 4ºC in an XL-1 analytical ultracentrifuge (Beckman 
Coulter, Inc., Fullerton, CA) with a UV-Vis detection system, using an An50Ti rotor and 
12 mm double-sector centerpieces. Absorbance scans (0.003 cm step size) were taken at 
280 nm. Differential sedimentation-coefficient distributions, c(s), were calculated by least 
squares boundary modeling of sedimentation velocity data using the program SEDFIT 
[23,24]. The values obtained from this analysis were corrected for solvent composition and 
temperature to obtain s20,w using the public domain software SEDNTERP, retrieved from 
the RASMB server [25]. 
 
Analytical gel filtration chromatography 
 MATX samples (100 µl containing a minimum of 50 µg) were injected on a 
Superose 12 10/300 GL gel filtration column equilibrated in buffer A containing 150 mM 
KCl. The flow rate was 0.3 ml/min and 210 µl fractions were collected while A280 was 
recorded. Elution and MAT activity measurements (100 µl) were performed as previously 
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described [26]. The protein standards used and their elution volumes were as follows: 
Dextran Blue (2000 kDa), 8.69 ml; apoferritin (443 kDa), 9.87 ml; β-amylase (200 kDa), 
11.34 ml; alcohol dehydrogenase (150 kDa), 12.07 ml; carbonic anhydrase (29 kDa), 15.12 
ml; and ATP (0.551 kDa), 19.26 ml. 
 
Electrophoresis 
 Denaturing gel electrophoresis was performed on 10% SDS-PAGE gels under 
reduced conditions, using the Laemmli buffer system. Samples of soluble (150 µg), 
inclusion bodies (30 µg) and refolded MATX (6 µg) were loaded per lane and stained 
using Coomassie blue R250. Densitometric scanning of the bands was carried out using the 
ImageJ software 1.37v (http://rsb.info.nih.gov/ij/). 
 
MAT activity measurements and kinetics 
 Activity assays were carried out at 37ºC as previously described [27], using a 
protein concentration of 0.05 mg/ml and the standard MAT reaction mixture containing 5 
mM methionine and 5 mM ATP in a final volume of 250 µl. Kinetics were performed 
using standard MAT reaction mixtures containing: i) 1-600 µM of the amino acid and 5 
mM ATP, for methionine kinetics; ii) 1-1500 µM of the nucleotide and 5 mM methionine, 
for ATP kinetics; iii) 0-13 mM MgSO4, for Mg2+ kinetics; and iv) 0-85 mM KCl, for K+ 
kinetics. DMSO stimulation was tested using reaction mixtures containing 60 µM 
methionine and 10% (v/v) DMSO. 
 
Tripolyphosphatase activity measurements 
 MATX tripolyphosphatase activity was measured following absorption at 750 nm 
as previously described [17]. Tripolyphosphate kinetics were carried out using 0-5 mM 
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triphosphate in the presence or absence of 50 µM AdoMet and using 0.05 mg/ml protein 
samples. 
 
Theoretical calculations of the pI and extinction coefficient. 
 Information from the amino acid sequence was used for theoretical calculation of 
the pI using a method previously described by Ribeiro and Sillero [28]. In addition, the 
extinction coefficient was estimated from the number of tryptophan and tyrosine residues 
in the sequence, and using extinction coefficients for these amino acids of 5550 and 1490 
M-1cm-1, respectively. 
 
Protein concentration determinations 
The protein concentration of the samples was measured routinely using the BioRad 
protein assay kit and bovine serum albumin as the standard. On the other hand, for CD and 
sedimentation velocity experiments protein concentration was determined from the A280 of 
the sample after 30 min incubation in 8 M urea using a calculated extinction coefficient of 
48610 M-1cm-1.  
 
MATX structural model and sequence alignment. 
 A structural model of the MATX monomer was prepared using the Swiss-Model 
server (http://swissmodel.expasy.org/), the protein sequence and the 2.05 Å resolution 
structure of the human MATα1 protein (PDB ID: 2OBV) as template (49.5% sequence 
identity)[29-31]. The model extends from residue 13 to 444 of the sequence and preserves 
the three-domain organization of all the previously crystallized MATs [7,16,17]. Sequence 
alignment of the MATs mentioned in the text was performed using the COBALT Multiple 
Alignment Tool (http://www.ncbi.nlm.nih.gov/tools/cobalt). 
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RESULTS AND DISCUSSION 
 MATX from Euglena gracilis belongs to the MAT family of enzymes characterized 
by the high level of sequence identity exhibited by its members [10]. Its ORF encodes for a 
protein of 471 residues, which means a notable increase in length as compared to most 
MATs (∼400 amino acids long). MATX has a theoretical pI of 5.91, similar to the values 
obtained to date for most members of the family (i.e. 5.9 for rat MAT III) [7,32]. 
Heterologous expression of the protein was initially carried out in E. coli using the plasmid 
pEXT5-MATX, which includes a His-tag at the protein N-terminal. However, the 
expression levels obtained were very low under all the conditions tested (growth 
temperature, cell density for induction, etc.). Addition of tags to other MATs, both at the 
N- or C-terminal ends, was previously shown to decrease the amount of soluble protein 
obtained [33], and hence the pT7.7-MATX plasmid that contains the MATX ORF without 
the His-tag was constructed. Growth and induction conditions of E. coli cells transformed 
with pT7.7-MATX were studied and optimized. The protein appeared in 10% SDS-PAGE 
gels with a calculated Mr of 57600, according to the mobility of the standards (Fig. 1), 
which is slightly above the calculated size. MAT activity was higher in soluble fractions of 
cultures induced at A600= 0.8 (Fig. 2), although no significant changes in the protein band 
intensity were detected by densitometric scanning of the stained gels (Fig. 1A). 
Overexpression of MAT enzymes produces a large decrease in cellular ATP levels, as its 
consumption is increased to produce AdoMet. Thus, it is possible that only low levels of 
expression allow cell survival, and hence that a larger cell number may led to an apparent 
constant level of MATX once a certain density is achieved, whereas the activity levels 
increase due to a larger contribution of the endogenous cMAT. The activity was also 
increased in soluble fractions of cultures grown at 30ºC as compared to those grown at 
37ºC (Fig. 3). Maximum induction with IPTG was already detected after a 3 h induction 
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period at both temperatures. However, in all the conditions tested most of the protein 
(~90%) was accumulated in inclusion bodies (Fig. 1B). The use of lower temperatures 
(20ºC) and IPTG concentrations was reported to improve Bacillus subtilis MAT (BsMAT) 
heterologous expression [34]. In our hands none of these conditions improved the results 
obtained and in fact the soluble protein was almost undetectable (data not shown). 
Therefore, the standard grown conditions were established to obtain MATX from inclusion 
bodies using 3 h IPTG induction at A600=0.6-0.8 and 37ºC and refolding from inclusion 
bodies was attempted. 
 Several parameters were studied using the inclusion bodies, in order to obtain the 
maximum amount of protein for refolding. These included the protein concentration, pH of 
the buffer and the concentrations of the solubilization agents, as previously described for 
mammalian MAT I/III refolding [32]. Inclusion bodies contain not only the desired 
overexpressed protein, but also bacterial membrane and cell wall and therefore the need to 
eliminate these extraneous proteins. For this purpose, the inclusion bodies were subjected 
to several washing steps with buffers including variable concentrations of urea (0-4 M) and 
Triton X-100 (0-5%) at pH 7. In contrast to MAT I/III, with a similar pI [32], a large 
amount of MATX was solubilized when using washing buffers containing >2 M urea, 
whereas the percentages of detergent examined did not cause such protein loss. Therefore, 
the standard washing conditions were established as two washes in the presence of 2 M 
urea and 5% Triton X-100.  
 Refolding of MATX from the washed inclusion bodies was then attempted. For this 
purpose, the protein was solubilized using a buffer containing 8 M urea, and the refolding 
protocol previously developed for rat MAT I/III [32]. However, for this protocol to be 
adapted to MATX several requirements had to be tested. First, the range of protein 
concentration at the solubilization step that renders the largest amount of active refolded 
 13 
MATX. According to the results obtained, this protein concentration was established 
between 1-3 mg/ml. Secondly, the intermediate urea concentration to be reached in the 
dilution step. This dilution was found to dramatically improve the yield of active-refolded 
MAT I/III [32], and hence expected to be crucial for MATX refolding. Our results indicate 
that achieving a urea concentration between 0.5-1 M before dialysis, and hence a protein 
concentration of 0.1-0.3 mg/ml, allowed the largest recovery of active protein (Fig. 4). 
Finally, the presence of 10 cysteine residues in the MATX sequence, and the crucial role 
that this type of amino acids have in all MATs studied to date [7,35,36], recommends the 
inclusion of a reducing agent in the dialysis buffer to avoid the production of off-pathway 
aggregates due to oxidation. Based on the data obtained, an intermediate dilution to 1 M 
urea followed by dialysis in the presence of 10 mM DTT was used as the standard 
procedure.  
 The refolded protein was further purified by ion exchange chromatography, and a 
single peak exhibiting MAT activity eluted in the presence of 100 mM KCl. The MATX 
content of this preparation was estimated to be >90% by densitometric scanning of the 
stained gels (Fig. 5). The purification results appear in Table 1, and show a remarkably 
lower yield at the dialysis step as compared to MAT I/III (25 vs. 88%) [32]. Given the high 
sequence identity level between MATs this result was unexpected, and demonstrated how 
highly homologous proteins can behave quite differently under similar conditions.  
 This highly purified MATX preparation was then used for characterization. The 
oligomeric state of the refolded protein was analyzed using gel filtration chromatography 
and sedimentation velocity. The elution volume of MATX (13.2 ml) was determined from 
MAT activity measurements of the fractions eluted from the gel filtration column (Fig. 6). 
According to the elution position of the markers on the Superose column, this elution 
volume corresponds to that expected for a globular protein of ∼70 kDa. However, the A280 
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profile indicates elution of the protein as two peaks in positions compatible with tetrameric 
and dimeric oligomers. In addition, sedimentation velocity experiments identify species 
with calculated s20,w values of 3.4 ± 0.1 and 6.4 ± 0.1 S. These hydrodynamic 
measurements are compatible with the presence in the sample of monomers (compact or 
globular) and compact dimers, according to the A280 measurements of sedimentation 
velocity experiments, from which only compact dimers were active as deduced from the 
gel filtration chromatography profile. Detection of tetrameric species could be ascribed to a 
partial association during sample concentration preceding gel filtration chromatography, 
whereas that of monomeric species could be due to partial denaturation of the sample 
during ultracentrifugation, phenomena described to occur with a variety of enzymes 
[37,38]. As deduced from these data, MATX is a new member of the growing group of 
homodimeric MATs that includes mammalian MAT III, archaeal MATs and 
Mycobacterium tuberculosis MAT [7,15,35,39,40]. The AdoMet synthesizing activity of 
some of these dimeric MATs is stimulated by DMSO at low methionine concentrations 
[7]. Therefore, we analyzed this stimulatory effect on MATX and found that this dimeric 
MAT is not stimulated under similar conditions (1.80 ± 0.15 vs. 1.67 ± 0.11 
µmol/min/mg). 
 MAT activity is dependent on divalent (Mg2+) cations and stimulated by 
monovalent (K+) ions [7], and MATX is not an exception to this rule. Its dependence on 
these essential cations was explored and the data obtained appear in Table 2. The affinity 
for the cations is in the millimolar range, similar values to those measured for refolded 
MAT III [32]. Kinetics for the substrates, methionine and ATP, showed Michaelis-Menten 
behavior, the calculated Km values being about half of those exhibited by MAT III (Table 
2)[32]. In addition, the Vmax is ∼18 fold higher than that of MAT III [32], and similar to 
that of E. coli MAT (cMAT)[6] or Methanococcus jannaschii MAT (Mj-MAT)[40]. The 
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tripolyphosphatase activity exhibited by the MAT family was also evaluated for MATX. 
Kinetics for PPPi showed a Vmax for this substrate similar to that shown by refolded-MAT 
III in the presence of 50 µM AdoMet [32]. MATX tripolyphosphatase activity was 
stimulated by AdoMet ∼23 fold, rendering a calculated Vmax  ∼2 fold larger than that of the 
AdoMet synthesis reaction as occurs for cMAT [6] (Table 2). However, this 2-fold 
increase in Vmax (1464.22 vs 2725.20 nmol/min/mg) is also observed when the AdoMet 
synthesis is measured as Pi using the colorimetric method (3349.33 ± 71.61 nmol/min/mg). 
This stimulation occurs without a significant change in affinity for the PPPi substrate 
(Table 2), in contrast to the decreased affinity shown by cMAT in the presence of AdoMet 
(∼4 fold)[6].  
 Structural characterization of refolded MATX was carried out using circular 
dichroism. Far-UV spectra were obtained (Fig. 7) and the overall secondary structure 
composition estimated by deconvolution (Table 3). The major elements were found to be 
the random coil and β-sheet as previously described for other members of the MAT family. 
Comparison of these data with the secondary structure composition published for other 
members of the MAT family showed an increase in the random coil component that is 
especially important when compared to archaeal or BsMAT [32,34,41]. The difference in 
subunit length between these MATs (471 vs. 400 residues)(Fig. 8C), and the fact that the 
insertions occur in loops [19], may account for such increased random coil content. In 
addition, some differences can also be expected from the diversity of programs used in this 
type of calculations by each laboratory. Near-UV spectra were also obtained (Fig. 7B), the 
main feature being the lack of signal at 265 and 295 nm. MATX contains five tryptophans 
(positions 181, 182, 314, 437 and 469) and fourteen tyrosines (positions 78, 148, 162, 195, 
232, 311, 336, 360, 375, 413, 419, 434, 446 and 449) per subunit, two types of residues 
with transitions in this area of the spectrum. Hence, a compensatory effect between signals 
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of both types of residues must occur to render this profile. Such a compensatory effect has 
been previously observed in near-UV CD spectra from Mj-MAT (containing 1 Trp and 13 
Tyr), despite the low degree of sequence conservation in archaeal MATs [41]. Moreover, 
the absence of a significant signal in the 250-270 nm range suggested the lack of 
disulphide bonds in the molecule, as expected from refolding being carried out under 
reducing conditions. 
 The sequence of MATX preserves the main blocks that characterize all the 
members of this family and that include the residues involved in substrate and cation 
binding (Fig. 8C) [10]. Residues involved in methionine binding locate to the N-terminal 
domain, the 27GHPDK31 stretch (block I), and to a loop connecting this domain with the 
central domain that includes F290. This phenylalanine is equivalent to F251 of rMATα1 that 
was shown to have its aromatic ring stacked against the methionine analogue used for 
crystallization [17]. D141 (block III), D186 and K188 (block IV) are equivalent to the residues 
involved in Mg2+ binding and catalysis. Moreover, residues involved in K+ coordination, 
G303 and R305, are also preserved  (block V). Overall the sequence presents a high level of 
conservation, the main difference being the ∼30 residue extension at the C-terminal end 
and an insertion comprising residues 218-248 according to the sequence alignment (Fig. 
8C). This high conservation allowed construction of a structural model using the MATX 
sequence and the structure of human MATα1 (PDB ID: 2OBV), its closest homologue. 
This model extended from residue 13 to 444 and preserved the three-domain organization 
of all MATs (Fig. 8). The main differences occur in the N-terminal domain, where the 
strands of the β-sheet seem longer, as well as the loop (residues 259-281) preceeding the 
last strand. In addition, one of the α-helixes in the outer side of this domain is also longer 
(residues 234-259), thus protruding to the environment. However, these changes do not 
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seem to affect positioning of the active site residues as compared with rMATα1 (Fig. 
8A)[17,41], and hence the high activity observed comparable to that of cMAT. 
 In summary, we have been able to produce and refold MATX using an 
heterologous system. The enzyme is a homodimer showing AdoMet synthesizing capacity, 
but its Vmax and the affinities displayed for ATP and methionine are closer to those of the 
cMAT homotetramer rather than to Mj-MAT or rMAT III dimers. MATX activity is also 
dependent on divalent and monovalent cations. Moreover, the enzyme exhibits the 
tripolyphosphatase activity typical of the MAT family that is stimulated in the presence of 
AdoMet. 
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FIGURE LEGENDS 
 
 Fig. 1. SDS-PAGE electrophoresis of soluble and insoluble fractions of MATX 
overexpressing cells. Cultures of E. coli cells transformed with pT7.7-MATX were grown 
at 37ºC to reach several cell densities (A600). At this point cultures were divided into two 
samples and grown for 3 additional hours in the absence (lanes 1, 2, 4 and 6) or presence 
(lanes 3, 5 and 7) of IPTG. The cells were harvested by centrifugation and lysed to obtain 
soluble and insoluble fractions. (A) Samples of the soluble (30 µl containing ∼150 µg) and 
(B) insoluble (20 µl containing ∼30 µg) fractions were loaded in SDS-PAGE gels. 
Induction was done at A600=0 (lane 1), 0.3, (lanes 2 and 3), 0.6 (lanes 4 and 5) and 0.8 
(lanes 6 and 7). The figure shows results of a typical experiment. 
 Fig. 2. MAT activity in soluble fractions of cultures induced at different cell 
densities at 37ºC. Cultures of E. coli cells transformed with pT7.7-MATX were grown at 
37ºC to reach several cell densities (A600). At this point cultures were divided into two 
samples and grown for 3 additional hours in the absence () or presence () of IPTG. The 
cells were harvested by centrifugation and lysed to obtain soluble and insoluble fractions. 
MAT activity was measured in the soluble fractions. The figure shows the mean ± SEM of 
a typical experiment carried out in triplicate. 
 Fig. 3. MAT activity in soluble fractions of cultures induced at 30ºC or 37ºC. 
Cultures of E. coli cells transformed with pT7.7-MATX were grown at 37ºC to reach 
A600= 0.8. At this point cultures were divided into two samples and grown for 3 additional 
hours in the absence () or presence () of IPTG at 30ºC (A) or 37ºC (B). The cells were 
harvested by centrifugation and lysed to obtain soluble and insoluble fractions. MAT 
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activity was measured in the soluble fractions. The figure shows the mean ± SEM of a 
typical experiment carried out in triplicate. 
 Fig. 4. Two step refolding of MATX from inclusion bodies. Washed inclusion 
bodies were solubilized in 8 M urea buffer and incubated for 2 h at 10ºC. The samples 
were then diluted to achieve final urea concentrations between 0.5-4M and immediately 
subjected to dialysis in the presence of 10 mM DTT. Samples were recovered and clarified 
by centrifugation and the soluble fraction assayed for MAT activity. The figure shows the 
mean ± SD of a typical experiment carried out in triplicate. 
 Fig. 5. SDS-PAGE of the MATX purification steps. The figure shows a scheme of 
the purification steps, where the number indicates the corresponding lane of the SDS-
PAGE gel. Samples (40 µl) of representative purification steps were prepared for SDS-
PAGE electrophoresis under reducing conditions and loaded on a 10% acrylamide gel. The 
samples correspond to: washed inclusion bodies solubilized in 8 M urea buffer (lane 1); 
refolded MATX (lane 2); the peak eluted from the Q-Sepharose cartridge (lane 3). MATX 
appear as the main band stained in all the fractions with an apparent Mr of 57600 
according to the standards: phosphorylase B (97400), bovine serum albumin (66200), 
ovalbumin (45000), carbonic anhydrase (31000) and soybean trypsin inhibitor (21500).  
 Fig. 6. Gel filtration chromatography of refolded MATX. MATX was refolded from 
inclusion bodies following the two-step protocol described under Materials and Methods, 
purified by ion exchange chromatography and dialyzed. A sample (100 µl containing ∼80 
µg) was injected on a Superose 12 10/300 GL column equilibrated in 50 mM Tris/HCl pH 
8, 10 mM MgSO4, 150 mM KCl. Elution was carried out at a flow rate of 0.3 ml/min, the 
A280 was recorded and 210 µl fractions were collected for MAT activity measurements. 
The elution volume of the markers was: Dextran Blue (8.69 ml); apoferritin (9.87 ml); β-
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amylase (11.34 ml); alcohol dehydrogenase (12.07 ml); carbonic anhydrase (15.12 ml); 
and ATP (19.26 ml). The figure shows results from a typical experiment. 
 Fig. 7. Far- and near-UV circular dichroism spectra of refolded MATX. Samples of 
purified refolded MATX were used to obtain (A) far- and (B) near-UV circular dichroism 
spectra. The protein concentration of the samples was 0.25 mg/ml and 1 mg/ml for far- and 
near-UV spectra, respectively. After baseline subtraction the observed ellipticities were 
converted to mean residue ellipticities using a mean molecular mass per residue of 110 Da. 
 Fig. 8. Comparison of monomer structures for rat MATα1 (crystal) and MATX 
(structural model) and alignment of MAT sequences. (A) The structural model constructed 
using the Swiss-Model server and human MATα1 (PDB ID: 2OBV) as template is shown. 
The arrows indicate extensions in the N-terminal domain that affect a loop and α-helix. 
The active site residues appear as sticks (greencyan) over which the sequences are 
indicated. (B) The structure of the rat MATα1 monomer (PDB ID: 1QM4) is depicted for 
comparison. The position of the N-terminal residue for each monomer is also indicated. 
(C) Alignment of the MAT sequence mentioned in the text, including that of human 
MATα1 the higher homologue used for construction of the structural model. 
 
 
 
 
 
 
 
 
 
 
 
 
 23 
 
 
 
 
 
 
 
TABLE 1 
Refolding and purification of MATXa,f 
 Total protein 
(mg)d 
Total enzyme 
unitse 
Specific activity 
(nmol/min/mg) 
Yield 
(%) 
Urea solubilizationb 91.89 0 <0.0001 100 
Dialysis + DTTc 22.99 24.88 ± 3.98 1153.71 ± 208.02 25.02 
Q-Sepharose 9.08 1.12 ± 0.39 1553.04 ± 238.61 9.88 
aWashed inclusion bodies were used for refolding.  
bSolubilization in the presence of 8 M urea for 2 h at 10ºC . 
cThe diluted sample was dialyzed against buffer A containing 10 mM DTT. 
dProtein concentration was determined by Bradford protein assay. 
eOne unit is the amount of enzyme that catalyzed the production of 1 µmol AdoMet per 
minute. 
fThe table shows results of a typical purification. 
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TABLE 2 
Kinetic parameters of MATX activities 
  MATX 
Vmax (nmol/min/mg) 1464.22 ± 164.26 
Km methionine (µM) 85.35 ± 28.42 
Km ATP (µM) 260.36 ± 38.90 
Km K+ (µM) 591.31 ± 76.64 
 
 
MAT activitya 
Km Mg2+ (mM) 1.72 ± 0.27 
   
Vmax (nmol/min/mg) 117.28 ± 15.73 
Km PPPi (µM) 82.75  ± 22.24 
Vmax (nmol/min/mg) + 50 µM AdoMet 2725.20 ± 115.15 
 
Tripolyphosphatase 
activityb 
Km PPPi (µM) + 50 µM AdoMet 130.65 ± 25.95 
aMAT activity measurements were carried out using 0.05 mg/ml protein samples for 30 
min. 
bTripolyphosphatase activity determinations were performed using 0.05 mg/ml protein 
concentrations for 10 min. 
 
 
 
 
 
 
 
 
 
 
 25 
 
 
 
 
 
 
 
 
TABLE 3 
Secondary structure composition of MATXa and comparison with other MATs 
 Secondary structure (%) 
 MATX MAT Ib MAT IIIb BsMATc 
α-helix  12.7 ± 0.5 23 ± 1.8 19 ± 1.1 81 
antiparallel 25.1 ± 0.5 β-sheet 
parallel 5.3 ± 0.5 
40 ± 1.2 34 ± 2.3 8 
β-turns  21.5 ± 0.5 18 ± 1.0 20 ± 0.8  
Random coil  35.9 ± 0.5 19 ± 1.8 27 ± 0.5 11 
aSecondary structure composition was calculated from the far-UV CD spectra using 
CDNN software (© G. Böhm) 
b Calculated using the Convex Constraint method, data from reference 32 
c Calculated using the CDpro software, data from reference 34 
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